Biocon covid drug
Biocon Likely To Seek Full Marketing Authorisation For Covid-19 Drug
Banking - Published date: .
Expects results from phase 4 study of itolizumab by end of this quarter Read more
Banking - Published date: .
Expects results from phase 4 study of itolizumab by end of this quarter Read more